Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2018
The purpose of this study is to assess the efficacy and safety of TAS5315 in combination with methotrexate in a 12 week or 36 week in participants with rheumatoid arthritis with inadequate response to methotrexate.
Epistemonikos ID: 659c9e6a73d4ec62b1291d8b9379a0f8f41dbdc2
First added on: Mar 23, 2022